Research & Development



  虎嘯山林,絕對不是夸張,身後的傳來的虎嘯有攝人魂魄嚇破人膽的效果,雲瑯明知道這是大王在耍賴,腳底下依舊不由自主的停頓了一下。   雲瑯想了一下道︰“留在這里其實也不錯,只要快活,哪里都是樂土。”大香蕉视频   大雪封山,外面天寒地凍,雲瑯想要給自己打幾樣合用的小工具都不成,就只好待在屋子里教老虎識字……大香蕉在线视频   雲瑯不知道國人是什麼時候開始通過祭奠來思念故去的祖先的。   太宰微笑道︰“能書寫自己姓名者,放眼天下已是萬中無一。爾雲姓出自于縉雲氏,是黃帝時夏官之後,以官名為姓氏,比老夫的烏姓要高出不止一籌啊。看你握筆嫻熟,雖然怪異,卻運轉自如,看來老夫撿到寶貝了。”大香蕉在线影院   雲瑯痛苦的轉過頭,他決定不再跟這種把自己性命當成一回事的人說話。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo